Rainer Metternich to head Roche's SMR group
This article was originally published in Scrip
Roche has appointed Dr Rainer Metternich head of small molecules research, succeeding Klaus Strein who is retiring from Roche. Dr Metternich will lead 800 scientists across Europe and the US. He formerly worked for companies such as Novartis, Schering and Merck & Co, and was most recently chief scientific officer and chief business officer at Caprotec.